Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maria Teresa Solomon"'
Autor:
Jose Alert, Maria Teresa Solomon, Nederlay Miranda, Eugenia Jorrín, Ivonne Chon, Jorge Juan Marinello, Patricia Lorenzo-Luaces, Tania Crombet
Publikováno v:
Cancer Biology & Therapy. 15:504-509
Nimotuzumab, a humanized antibody targeting epidermal growth factor receptor, has potent anti-proliferative, anti-angiogenic, and pro-apoptotic effects in vitro and in vivo. It also reduces the number of radio-resistant CD133(+) glioma stem cells. Th
Autor:
Margarita Elena Sánchez Padín, Jhonaiky Armanda Peguero Garó, María Teresa Solomon Cardona, Carmen Elena Viada González
Publikováno v:
Revista Cubana de Medicina Militar, Vol 51, Iss 4, Pp e02202170-e02202170 (2022)
Introduction: Spontaneous intracerebral hematoma is the form of stroke with the highest mortality and morbidity rates. There is no consensus as to which patients benefit from surgical evacuation of the hematoma and, furthermore, postoperative mortali
Externí odkaz:
https://doaj.org/article/97c3adbdac5f4708ae5719abed9a2672
Autor:
María Teresa Solomón Cardona, Bárbara O. Estupiñán Díaz, Zenaida M. Hernández-Díaz, Tania de la Paz Bermúdez, Nelson E. Quintanal Cordero, Héctor Gómez Suárez
Publikováno v:
Anales de la Academia de Ciencias de Cuba, Vol 12, Iss 3 (2022)
Presentamos un paciente de 52 años masculino, que debutó con crisis epiléptica y en los estudios imagenológicos se encontraron lesiones múltiples supratentoriales hemisféricas cerebrales que se realzaron con contraste, considerando un gliobla
Externí odkaz:
https://doaj.org/article/8141367657864ac99b0f079fd116568c
Autor:
F. Bach, Rafael Dominguez, Maria Teresa Solomon, Javier Figueredo, Normando Iznaga, Nelson Quintanal, Julio Cesar Selva, Mauricio Catala, Jose Vaquer, Jorge Juan Marinello, Jose Alert, Carolina Toledo, Tania Crombet Ramos, Patrcia Lorenzo Luaces, Silvia Salva, Martha Gonzalez Griego
Publikováno v:
Journal of Clinical Oncology. 30:2515-2515
2515 Background: Despite remarkable advances in multimodal therapy, high grade glioma (HGG) patients still face a poor prognosis. EGFR is well validated as a primary contributor of HGG initiation and progression. Nimotuzumab is a humanized monoclonal
Autor:
Jose Vaquer, Rafael Domíngez, Martha Gonzalez Griego, Mauricio Catala, Tania Crombet, Javier Ballesteros, Nelson Quintanal, Jorge Juan Marinello, Patricia Lorenzo Luaces, Maria Teresa Solomon, Silvia Salva, Ferdinand Bach, Javier Figueredo, Julio Cesar Selva, Jose Alert, Juan Antonio Martell, Niurys de-Castro, Carolina Toledo
Publikováno v:
Addi. Archivo Digital para la Docencia y la Investigación
instname
BMC Cancer
instname
BMC Cancer
Background The prognosis of patients bearing high grade glioma remains dismal. Epidermal Growth Factor Receptor (EGFR) is well validated as a primary contributor of glioma initiation and progression. Nimotuzumab is a humanized monoclonal antibody tha
Autor:
María Teresa Solomon Cardona, Esteban Roig Fabre, Marlon Pila Bandera, Wilfredo Domínguez, Tania Crombet Ramos
Publikováno v:
Revista Cubana de Cirugía, Vol 53, Iss 3, Pp 244-255
Externí odkaz:
https://doaj.org/article/e01390120af147549b00097e3ebf2f8f